Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neuromuscular Disorders

• Publication date

  2006-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.NMD.2006.08.011PMID 17049859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of homozygous and heterozygous SMN deletions of spinal muscular atrophy in a single assay with multiplex ligation-dependent probe amplification.

  2005cited by this paper
• Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy

  2005cited by this paper
• New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations

  2004cited by this paper
• Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2

  2004cited by this paper
• The SMN complex.

  2004cited by this paper
• Spinal muscular atrophy: molecular genetics and diagnostics

  2004cited by this paper
• Prevalence of SMN1 deletion and duplication in carrier and normal populations: implication for genetic counselling

  2003cited by this paper
• Determination of SMN1 and SMN2 copy number using TaqMan™ technology

  2003cited by this paper
• Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

  2002cited by this paper
• Molecular analysis of SMN, NAIP and P44 genes of SMA patients and their families.

  2001influential reference
• Best practice guidelines for molecular analysis in spinal muscular atrophy

  2001cited by this paper
• SMA carrier testing – validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion

  2000cited by this paper
• The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.

  2000cited by this paper
• Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7

  1997cited by this paper
• Allelic association and deletions in autosomal recessive proximal spinal muscular atrophy: association of marker genotype with disease severity and candidate cDNAs.

  1995cited by this paper
• De novo and inherited deletions of the 5q13 region in spinal muscular atrophies.

  1994cited by this paper
• Association between Ag1-CA alleles and severity of autosomal recessive proximal spinal muscular atrophy.

  1994cited by this paper
• Quantitation of muscle function in children: A prospective study in duchenne muscular dystrophy

  1982cited by this paper
• HUMAN MUTATION 24:417^427 (2004) METHODS Molecular Analysis of SMA Patients Without Homozygous SMN1 Deletions Using a New Strategy for Identification of SMN1 Subtle Mutations

  year unknowncited by this paper

• Outcomes of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in the Valencian Community

  2025cites this paper
• A More Clinically Effective Long-read Sequencing-based Approach for Comprehensive Analysis of Spinal Muscular Atrophy.

  2025cites this paper
• Performance of cellulose-based card for direct genetic testing of spinal muscular atrophy

  2025cites this paper
• Carrier screening for multiple complex monogenic diseases using long-read sequencing: a population-based study of premarital couples in Shanghai

  2025cites this paper
• Carrier Screening and Diagnosis for Spinal Muscular Atrophy Using Droplet Digital PCR Versus MLPA: Analytical Validation and Early Test Outcome

  2024cites this paper
• Diagnosis of challenging spinal muscular atrophy cases with long-read sequencing.

  2024cites this paper
• Optimized MLPA workflow for spinal muscular atrophy diagnosis: identification of a novel variant, NC_000005.10:g.(70919941_70927324)del in isolated exon 1 of SMN1 gene through long-range PCR

  2024cites this paper
• Spinal muscular atrophy: Molecular mechanism of pathogenesis, diagnosis, therapeutics, and clinical trials in the Indian context

  2024cites this paper
• Motor patterns of patients with spinal muscular atrophy suggestive of sensory and corticospinal contributions to the development of locomotor muscle synergies

  2024cites this paper
• Evaluating the clinical efficacy of a long-read sequencing-based approach for carrier screening of spinal muscular atrophy

  2024cites this paper
• A rapid and easy-to-use spinal muscular atrophy screening tool based on primers with high specificity and amplification efficiency for SMN1 combined with single-stranded tag hybridization assay

  2024cites this paper
• Spinal Muscular Atrophy: An Evolving Scenario through New Perspectives in Diagnosis and Advances in Therapies

  2023cites this paper
• Consensus from the Brazilian Academy of Neurology for the diagnosis, genetic counseling, and use of disease-modifying therapies in 5q spinal muscular atrophy

  2023cites this paper
• A high-fidelity long-read sequencing-based approach enables accurate and effective genetic diagnosis of spinal muscular atrophy.

  2023cites this paper
• Nusinersen demonstrates effectiveness in treating spinal muscular atrophy: findings from a three-year nationwide study in Korea

  2023cites this paper
• Comparison of the accuracy of multiplex digital PCR versus multiplex ligation-dependent probe amplification in quantification of the survival of motor neuron genes copy numbers.

  2023cites this paper
• Neonatal screening for spinal muscular atrophy: A pilot study in Brazil

  2023cites this paper
• Studying carrier frequency of spinal muscular atrophy in the State of Qatar and comparison to other ethnic groups: Pilot study

  2023cites this paper
• An Effective and Universal Long-Read Sequencing-Based Approach for SMN1 2 + 0 Carrier Screening through Family Trio Analysis.

  2023cites this paper
• Lessons from Real Life Experience: Importance of In-House Sequencing and Smart Ratio-Based Real-Time PCR Outperform Multiplex Ligation-Dependent Probe Amplification in Prenatal Diagnosis for Spinal Muscular Atrophy: Bench to Bedside Diagnosis

  2023cites this paper
• Detection of SMN1 loss with PCR-based screening test

  2023cites this paper
• Spinal Muscular Atrophy: An Overview

  2023cites this paper
• Time-Efficacy in SMA Type 1 and 2 Cases Treated with Nusinersen

  2023cites this paper
• Evaluation of Exonic Copy Numbers of SMN1 and SMN2 Genes in SMA.

  2022cites this paper
• Single-Tube Multiplex Digital Polymerase Chain Reaction Assay for Molecular Diagnosis and Prediction of Severity of Spinal Muscular Atrophy.

  2022cites this paper
• Comprehensive SMN1 and SMN2 profiling for spinal muscular atrophy analysis using long-read PacBio HiFi sequencing

  2022cites this paper
• Comprehensive analysis of spinal muscular atrophy (CASMA): SMN1 copy number, intragenic mutation and 2 + 0 carrier analysis by third-generation sequencing.

  2022cites this paper
• MLPA analysis for molecular diagnosis of spinal muscular atrophy and correlation of 5q13.2 genes with disease phenotype in Egyptian patients

  2022cites this paper
• The Importance of Digging into the Genetics of SMN Genes in the Therapeutic Scenario of Spinal Muscular Atrophy

  2021cites this paper
• Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development

  2021influential citation
• Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan

  2021cites this paper
• Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy

  2021cites this paper
• An Atypical Case of Progressive Spinal Amyotrophy (Type I) Likely Explained by Genetic Modifiers Case Report

  2021cites this paper
• Beyond copy number: A new, rapid, and versatile method for sequencing the entire SMN2 gene in SMA patients

  2021influential citation
• Detection of SMN1 to SMN2 gene conversion events and partial SMN1 gene deletions using array digital PCR

  2021cites this paper
• Phenotypes of SMA patients retaining SMN1 with intragenic mutation.

  2021cites this paper
• Detection of Spinal Muscular Atrophy Patients Using Dried Saliva Spots

  2021cites this paper
• Development and validation of a 4-color multiplexing spinal muscular atrophy (SMA) genotyping assay on a novel integrated digital PCR instrument

  2020cites this paper
• NGS-based spinal muscular atrophy carrier screening of 10,585 diverse couples in China: a pan-ethnic study

  2020cites this paper
• Polymerase chain reaction detection methods of Survival Motor Neuron genes: a review

  2020cites this paper
• Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data

  2020cites this paper
• Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data

  2020cites this paper
• Practical guidelines to manage discordant situations of SMN2 copy number in patients with spinal muscular atrophy

  2020cites this paper
• Intragenic and structural variation in the SMN locus and clinical variability in spinal muscular atrophy

  2020cites this paper
• The frequency of SMN gene variants lacking exon 7 and 8 is highly population dependent

  2019cites this paper
• Carrier screening for spinal muscular atrophy with a simple test based on melting analysis

  2019cites this paper
• Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype

  2019cites this paper
• Validation of a Fast, Robust, Inexpensive, Two-Tiered Neonatal Screening Test algorithm on Dried Blood Spots for Spinal Muscular Atrophy

  2019cites this paper
• Spinal muscular atrophy – a revisit of the diagnosis and treatment modalities

  2019cites this paper
• High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR

  2019cites this paper
• One Year of Newborn Screening for SMA – Results of a German Pilot Project

  2019cites this paper
• Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry

  2019cites this paper
• Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data

  2019cites this paper
• Kobe University Repository : Kernel タイトル Tit le SMA Screening System Using Dried Blood Spots on Filter Paper : Applicat ion of COP-PCR to the SMN 1 Delet ion Test 著者

  2018cites this paper
• Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.

  2018cites this paper
• Correlation between SMA type and SMN2 copy number revisited: An analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases.

  2018cites this paper
• Evaluation and comparison of three assays for molecular detection of spinal muscular atrophy

  2017cites this paper
• Spinal muscular atrophy carriers with two SMN1 copies.

  2017cites this paper
• Genetics of Spinal Muscular Atrophy

  2017cites this paper
• Genetic screening of spinal muscular atrophy using a real-time modified COP-PCR technique with dried blood-spot DNA.

  2017cites this paper
• The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN1 copy-number and sequence variant analysis by massively parallel sequencing

  2017cites this paper
• Mutation Spectrum of Survival Motor Neuron Gene in Spinal Muscular Atrophy

  2017cites this paper
• Relationships between long-term observations of motor milestones and genotype analysis results in childhood-onset Japanese spinal muscular atrophy patients.

  2017cites this paper
• Clinical Characteristics of Spinal Muscular Atrophy in Korea Confirmed by Genetic Analysis

  2017cites this paper
• Genotype-phenotype correlation of SMN locus genes in spinal muscular atrophy children from Argentina.

  2016cites this paper
• Mutation Spectrum of the Survival of Motor Neuron 1 and Functional Analysis of Variants in Chinese Spinal Muscular Atrophy.

  2016cites this paper
• Telomeric Region of the Spinal Muscular Atrophy Locus Is Susceptible to Structural Variations.

  2016cites this paper
• Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases

  2016cites this paper
• Molecular Genetic Diagnosis for a Family with Type I Spinal Muscular Atrophy (SMA) via Analysis of the Survival Motor Neuron (SMN) Gene

  2016cites this paper
• Genetic findings of Cypriot spinal muscular atrophy patients

  2015cites this paper
• Copy Number Variation Analysis by Ligation-Depen- dent PCR Based on Magnetic Nanoparticles and Chem-

  2015cites this paper
• Evaluation and characterization of a high-resolution melting analysis kit for rapid carrier-screening test of spinal muscular atrophy

  2015cites this paper
• A Rapid, Accurate and Simple Screening Method for Spinal Muscular Atrophy: High-Resolution Melting Analysis Using Dried Blood Spots on Filter Paper.

  2015cites this paper
• Newborn screening for spinal muscular atrophy: Anticipating an imminent need.

  2015cites this paper
• SMA screening system using dried blood spots on filter paper: application of COP-PCR to the SMN1 deletion test.

  2015cites this paper
• Molecular Genetic Diagnosisfor a Family with Type I SpinalMuscular Atrophy (SMA) viaAnalysis of the Survival MotorNeuron (SMN) Gene

  2015cites this paper
• Colourimetric-based method for the diagnosis of spinal muscular atrophy using gold nanoprobes.

  2015cites this paper
• Molecular characterization and copy number of SMN1, SMN2 and NAIP in Chinese patients with spinal muscular atrophy and unrelated healthy controls

  2015cites this paper
• Copy Number Variation Analysis by Ligation-Dependent PCR Based on Magnetic Nanoparticles and Chemiluminescence

  2015cites this paper
• [Multiplex ligation-dependent probe amplification detection of spinal muscular atrophy type I in a 3 months' patient and wide detection of healthy carriers in the family].

  2014cites this paper
• Integrative Genetic Characterization and Phenotype Correlations in Pheochromocytoma and Paraganglioma Tumours

  2014cites this paper
• Charting the Genetic Landscape and Clonal Architectures of Pheochromocytoma

  2014cites this paper
• A Paucisymptomatic Neuromuscular Disease Mimicking Type III 5q-SMA With Complex Rearrangements in the SMN Gene

  2014cites this paper
• An Ashkenazi Jewish SMN1 haplotype specific to duplication alleles improves pan-ethnic carrier screening for spinal muscular atrophy

  2013cites this paper
• Gene SMN Rearrangements in the A Paucisymptomatic Neuromuscular Disease Mimicking Type III 5 q-SMA With Complex

  2013cites this paper
• Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy.

  2013cites this paper
• Spinal Muscular Atrophy: From Gene Discovery to Clinical Trials

  2013influential citation
• Molecular analysis of SMN 1 , SMN 2 , NAIP , GTF 2 H 2 , and H 4 F 5 genes in 157 Chinese patients with spinal muscular atrophy ☆

  2013cites this paper
• Childhood spinal muscular atrophy: controversies and challenges.

  2012cites this paper
• Confirmation of the Spinal Motor Neuron Gene 2 (SMN2) Copy Numbers by Real-time PCR

  2012cites this paper
• Homozygous SMN1 exons 1–6 deletion: Pitfalls in genetic counseling and general recommendations for spinal muscular atrophy molecular diagnosis

  2012influential citation
• Modification of phenotype by SMN2 copy numbers in two Chinese families with SMN1 deletion in two continuous generations.

  2012cites this paper
• High-resolution melting (HRM) analysis as a feasible method for detecting spinal muscular atrophy via dried blood spots.

  2012cites this paper
• Use of the MLPA Assay in the Molecular Diagnosis of Gene Copy Number Alterations in Human Genetic Diseases

  2012cites this paper
• Accuracy of Marker Analysis, Quantitative Real-Time Polymerase Chain Reaction, and Multiple Ligation-Dependent Probe Amplification to Determine SMN2 Copy Number in Patients with Spinal Muscular Atrophy

  2011cites this paper
• Establishment of a molecular diagnostic system for spinal muscular atrophy experience from a clinical laboratory in china.

  2011cites this paper
• Spinal muscular atrophy

  2011cites this paper
• Carrier Screening for Spinal Muscular Atrophy (SMA) in 107,611 Pregnant Women during the Period 2005–2009: A Prospective Population-Based Cohort Study

  2011cites this paper
• Large-scale population screening for spinal muscular atrophy: Clinical implications

  2011cites this paper
• New Approaches in Molecular Diagnosis and Population Carrier Screening for Spinal Muscular Atrophy

  2011influential citation